Prostate cancer: 7. Radiation therapy for localized disease
| Table 1: Overall and cause-specific survival rates among patients with early-stage (T1 or T2) prostate cancer who underwent external beam radiation therapy | ||||||
| 5-year survival rate, % | 10-year survival rate, % | |||||
| Study | No. of patients | Tumour stage | Overall | Cause specific | Overall | Cause specific |
| Duncan et al5 | 70 341 |
T1 T2 |
83.8 81.8 |
93 92 |
57.8 53.6 |
79 66 |
| Perez et al6 | 48 252 |
T1b T2 |
85 82 |
78 76 |
70 65 |
60 56 |
| Shipley et al7 | 126 | T2 | 85 | – | – | – |
| Zagars et al8 | 32 82 |
T1b T2 |
74 93 |
90 89 |
68 70 |
85 |
